首页>
外国专利>
40-O-(2-hydroxyethyl)rapamycin in combination with exemestane or letrozole for use in the treatment of breast tumour
40-O-(2-hydroxyethyl)rapamycin in combination with exemestane or letrozole for use in the treatment of breast tumour
展开▼
机译:40-O-(2-羟乙基)雷帕霉素联合依西美坦或来曲唑用于乳腺肿瘤的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
40-O-(2-hydroxyethyl)rapamycin (everolimus) is proposed for use in combination with exemestane or letrozole in the treatment of breast tumour. Disclosed is antiproliferative and antiangiogenic activity of 40-O-(2-hydroxyethyl)rapamycin when used in combination with another active agent or alone.
展开▼